EMERGENT BIOSOLUTIONS INC. Repayments of Long-Term Debt
EMERGENT BIOSOLUTIONS INC. (EBS) reported Repayments of Long-Term Debt of $150.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for the quarter ending 2015-12-31 was $0.00.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for the quarter ending 2015-09-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for the quarter ending 2015-06-30 was $0.00.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for fiscal 2018 was $2.80M.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for fiscal 2017 was $0.00.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for fiscal 2016 was $0.00.
- EMERGENT BIOSOLUTIONS INC. repayments of long-term debt for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $150.00M 10-Q · filed 2026-08-06 | |||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | |||
| 2018-12-31 | $2.80M 10-K · filed 2019-02-22 | |||
| 2017-12-31 | $0.00 10-K · filed 2019-02-22 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-22 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 10-K · filed 2017-02-28 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $0.00 10-Q · filed 2015-11-06 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $0.00 10-Q · filed 2015-08-06 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-08 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $0.00 derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $0.00 derived: sum of 2 quarters · filed 2017-02-28 | $0.00 derived: sum of 3 quarters · filed 2017-02-28 | $62.00M 10-K · filed 2017-02-28 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $0.00 derived: sum of 2 quarters · filed 2015-11-06 | $62.00M 10-Q · filed 2015-11-06 | $121.42M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $62.00M 10-Q · filed 2015-08-06 | $121.42M derived: sum of 3 quarters · filed 2016-02-29 | $122.54M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $62.00M 10-Q · filed 2015-05-08 | $121.42M derived: sum of 2 quarters · filed 2016-02-29 | $122.54M derived: sum of 3 quarters · filed 2016-02-29 | $123.66M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $59.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $60.54M derived: sum of 2 quarters · filed 2016-02-29 | $61.66M derived: sum of 3 quarters · filed 2016-02-29 | $62.77M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.23M derived: sum of 2 quarters · filed 2014-11-10 | $3.35M 10-Q · filed 2014-11-10 | $4.19M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-06-30 | $1.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $2.23M 10-Q · filed 2014-08-08 | $3.08M derived: sum of 3 quarters · filed 2015-03-09 | $3.79M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-03-31 | $1.12M 10-Q · filed 2014-05-12 | $1.96M derived: sum of 2 quarters · filed 2015-03-09 | $2.67M derived: sum of 3 quarters · filed 2015-03-09 | $3.14M derived: sum of 4 quarters · filed 2015-03-09 |
| 2012-12-31 | $841.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $1.56M derived: sum of 2 quarters · filed 2015-03-09 | $2.02M derived: sum of 3 quarters · filed 2015-03-09 | $10.23M 10-K · filed 2015-03-09 |
| 2012-09-30 | $716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | $1.18M derived: sum of 2 quarters · filed 2013-11-08 | $9.39M 10-Q · filed 2013-11-08 | $9.95M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-06-30 | $467.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $8.67M 10-Q · filed 2013-08-06 | $9.23M derived: sum of 3 quarters · filed 2014-03-10 | $16.04M derived: sum of 4 quarters · filed 2014-03-10 |
| 2012-03-31 | $8.20M 10-Q · filed 2013-05-03 | $8.77M derived: sum of 2 quarters · filed 2014-03-10 | $15.57M derived: sum of 3 quarters · filed 2014-03-10 | |
| 2011-12-31 | $563.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $7.37M derived: sum of 2 quarters · filed 2014-03-10 | $15.49M 10-K · filed 2014-03-10 | |
| 2011-09-30 | $6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-01 | $14.93M 10-Q · filed 2012-11-01 | ||
| 2011-06-30 | $8.12M 10-Q · filed 2012-08-03 | |||
| 2010-12-31 | $33.29M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |